News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,753 Results
Type
Article (85624)
Company Profile (703)
Press Release (745426)
Section
Business (231974)
Career Advice (4115)
Deals (39670)
Drug Delivery (120)
Drug Development (90639)
Employer Resources (194)
FDA (17928)
Job Trends (17279)
News (395090)
Policy (39598)
Tag
Academia (2972)
Alliances (56518)
Alzheimer's disease (1374)
Approvals (17892)
Artificial intelligence (149)
Bankruptcy (396)
Best Places to Work (12482)
Biotechnology (485)
Breast cancer (168)
Cancer (1371)
Career advice (3518)
CAR-T (116)
Cell therapy (332)
Clinical research (71849)
Collaboration (533)
Compensation (257)
COVID-19 (2798)
C-suite (121)
Data (1251)
Diabetes (136)
Diagnostics (6628)
Earnings (94200)
Employer resources (166)
Events (126848)
Executive appointments (401)
FDA (18529)
Funding (443)
Gene therapy (229)
GLP-1 (668)
Government (5031)
Healthcare (20686)
Infectious disease (2878)
Inflammatory bowel disease (128)
Interviews (808)
IPO (17600)
Job creations (5179)
Job search strategy (2856)
Layoffs (495)
Legal (10025)
Lung cancer (206)
Manufacturing (209)
Medical device (14262)
Medtech (14267)
Mergers & acquisitions (22119)
Metabolic disorders (445)
Neuroscience (1714)
NextGen: Class of 2025 (7657)
Non-profit (5054)
Northern California (1645)
Obesity (248)
Opinion (252)
Patents (115)
People (64309)
Pharmaceutical (142)
Phase I (22169)
Phase II (31223)
Phase III (23505)
Pipeline (548)
Postmarket research (3541)
Preclinical (9979)
Radiopharmaceuticals (245)
Rare diseases (265)
Real estate (7371)
Regulatory (26016)
Research institute (2640)
Resumes & cover letters (649)
Southern California (1426)
Startups (4276)
United States (14768)
Vaccines (638)
Weight loss (196)
Date
Today (21)
Last 7 days (350)
Last 30 days (1523)
Last 365 days (33247)
2025 (1332)
2024 (34089)
2023 (42569)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (219)
Asia (49439)
Australia (8721)
California (3772)
Canada (1255)
China (338)
Colorado (119)
Connecticut (162)
Europe (113073)
Florida (437)
Georgia (103)
Illinois (376)
Indiana (213)
Kansas (105)
Maryland (666)
Massachusetts (3079)
Michigan (158)
Minnesota (268)
New Jersey (1061)
New York (1043)
North Carolina (844)
Northern California (1645)
Ohio (127)
Pennsylvania (834)
South America (1646)
Southern California (1426)
Texas (487)
Washington State (410)
831,753 Results for "palisade bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palisade Bio Appoints Brian Feagan, MD, FRCPC, to its Clinical Advisory Board
December 17, 2024
·
5 min read
Biotech Beach
Palisade Bio to Present at the Virtual Investor Pitch Conference - June 10, 2024
Palisade Bio, Inc. announced that it will present at the Virtual Investor Pitch Conference on June 17, 2024 at 12:00 PM ET.
June 10, 2024
·
1 min read
Press Releases
Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 3, 2025
January 6, 2025
·
1 min read
Business
Palisade Bio Appoints Margery Fischbein to its Board of Directors
Palisade Bio, Inc. announced it has appointed Margery Fischbein to its Board of Directors.
May 7, 2024
·
4 min read
Biotech Beach
Palisade Bio to Participate in the Virtual Investor Lunch Break Event
Palisade Bio, Inc. announced that it will present at the Virtual Investor Lunch Break Featuring Palisade Bio event on Tuesday, April 16, 2024 at 12:00 PM ET.
April 11, 2024
·
1 min read
Business
Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
Palisade Bio, Inc. today provided an update on key areas of progress for its previously announced strategic collaboration with Strand Life Sciences (“Strand”), a leading bioinformatics specialist, aimed at advancing precision medicine for ulcerative colitis (UC) therapy.
June 21, 2024
·
4 min read
Business
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Palisade Bio, Inc. today reported its financial results for the first quarter 2024 and provided a business update.
May 14, 2024
·
10 min read
Press Releases
Palisade Bio Completes All Five SAD Cohorts and Advances to MAD Cohorts of Phase 1a/b Study of PALI-2108 for Treatment of Ulcerative Colitis
January 16, 2025
·
6 min read
Press Releases
Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
December 16, 2024
·
6 min read
Biotech Beach
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108
Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that the Canadian Intellectual Property Office (CIPO) has issued a Notice of Allowance for patent application number 3,174,137 titled, “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors.”
June 11, 2024
·
5 min read
1 of 83,176
Next
